Dana Investment Advisors, Inc. Ligand Pharmaceuticals Inc Transaction History

Dana Investment Advisors, Inc.

$3.19 Billion
Q3 2025

A detailed history of Dana Investment Advisors, Inc. transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Dana Investment Advisors, Inc. holds 72,659 shares of LGND stock, worth $14.6 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares

72,659

Previous 73,169 0.7%

Holding current value

$14.6 Million

Previous $8.32 Million 54.74%

% of portfolio

0.4%

Previous 0.28%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 10, 2025	SELL	$112.56 - $177.14 $57,405 - $90,341	-510 Reduced 0.7%	72,659 $12.9 Million
Q2 2025 Aug 13, 2025	SELL	$96.67 - $118.22 $110,687 - $135,361	-1,145 Reduced 1.54%	73,169 $8.32 Million
Q1 2025 May 15, 2025	SELL	$105.14 - $122.23 $201,343 - $234,070	-1,915 Reduced 2.51%	74,314 $7.81 Million
Q4 2024 Feb 06, 2025	SELL	$99.95 - $129.9 $437,081 - $568,052	-4,373 Reduced 5.43%	76,229 $8.17 Million
Q3 2024 Nov 13, 2024	SELL	$82.7 - $110.11 $781,845 - $1.04 Million	-9,454 Reduced 10.5%	80,602 $8.07 Million

Q2 2024 Aug 27, 2024	BUY	$68.53 - $87.91 $5.03 Million - $6.45 Million	73,342 Added 438.81%	90,056 $7.59 Million
Q2 2024 Aug 13, 2024	SELL	$68.53 - $87.91 $4.05 Million - $5.2 Million	-59,132 Reduced 77.96%	16,714 $1.41 Million
Q1 2024 May 15, 2024	BUY	$68.64 - $89.2 $5.21 Million - $6.77 Million	75,846 New	75,846 $5.54 Million
Q4 2020 Feb 11, 2021	SELL	$80.55 - $106.05 $1.44 Million - $1.9 Million	-17,903 Closed	0 $0
Q3 2020 Nov 10, 2020	SELL	$89.56 - $126.72 $107,830 - $152,570	-1,204 Reduced 6.3%	17,903 $1.71 Million
Q2 2020 Aug 11, 2020	SELL	$68.28 - $123.65 $102,283 - $185,227	-1,498 Reduced 7.27%	19,107 $2.14 Million
Q1 2020 May 13, 2020	BUY	$63.37 - $107.88 $255,381 - $434,756	4,030 Added 24.31%	20,605 $1.5 Million
Q4 2019 Feb 11, 2020	SELL	$96.94 - $113.59 $130,869 - $153,346	-1,350 Reduced 7.53%	16,575 $1.73 Million
Q3 2019 Nov 12, 2019	SELL	$86.25 - $120.16 $14,403 - $20,066	-167 Reduced 0.92%	17,925 $1.78 Million
Q2 2019 Aug 13, 2019	BUY	$107.38 - $129.34 $187,270 - $225,568	1,744 Added 10.67%	18,092 $2.07 Million
Q1 2019 May 15, 2019	BUY	$105.93 - $142.47 $415,351 - $558,624	3,921 Added 31.55%	16,348 $2.06 Million
Q4 2018 Feb 14, 2019	BUY	$128.36 - $272.13 $151,464 - $321,113	1,180 Added 10.49%	12,427 $1.69 Million
Q3 2018 Nov 14, 2018	SELL	$211.18 - $274.49 $413,701 - $537,725	-1,959 Reduced 14.83%	11,247 $3.09 Million
Q2 2018 Aug 01, 2018	SELL	$150.77 - $207.98 $537,042 - $740,824	-3,562 Reduced 21.24%	13,206 $0
Q1 2018 May 15, 2018	SELL	$138.63 - $182.62 $208,915 - $275,208	-1,507 Reduced 8.25%	16,768 $2.77 Million
Q4 2017 Feb 13, 2018	SELL	$128.36 - $147.04 $77,401 - $88,665	-603 Reduced 3.19%	18,275 $0
Q3 2017 Nov 15, 2017	BUY	$120.91 - $137.94 $2.28 Million - $2.6 Million	18,878	18,878 $2.57 Million

Others Institutions Holding LGND

# of Institutions

343

Shares Held

20.5M

Call Options Held

19K

Put Options Held

11.5K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $3.39B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dana Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Dana Investment Advisors, Inc. with notifications on news.

Account

Dana Investment Advisors, Inc. Ligand Pharmaceuticals Inc Transaction History